Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Bipolar disorder is a ...
When it comes to mental health disorders, few are as prevalent - or as misunderstood - as bipolar disorder. It's a mental health condition that some 4.4% of U.S. adults experience at some time in ...
Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can impact daily functioning and behavior. Although bipolar disorder is a chronic ...
Uzedy administered once every 2 months is not recommended for the maintenance treatment of bipolar I disorder. The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release ...
Bipolar disorder exists on a spectrum rather than as a single, uniform condition. This fundamental characteristic explains why two people with the same diagnosis can experience dramatically different ...
Following the high profile suicide of iconic fashion designer Kate Spade, we are shedding light on a silent killer. Bipolar disorder (once known as manic depression or manic-depressive disorder) ...
Medically reviewed by Mary Choy, PharmDMedically reviewed by Mary Choy, PharmD Trileptal (oxcarbazepine) is an anticonvulsant drug approved by the U.S. Food and Drug Administration (FDA) to treat ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Trisha Suppes, MD, ...
As a premier non-profit behavioral health system, our residential program for boys and girls, ages 6-17, treats a wide range of mental health disorders. We also offer a dual diagnosis program for ...
The first IOP we offer is an in-person group for those struggling with mental health diagnoses (Anxiety, Depression, Bipolar, PTSD, etc.). This group meets Mondays, Wednesdays, and Fridays from 2:00-5 ...
Hayes et al 12 conducted one of the most recent large studies to compare lithium with newer second-generation antipsychotics as maintenance monotherapy for bipolar disorder. The authors concluded that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results